Anzu Special Acquisition Corp I
ANZUU
NASDAQ Capital Market7.09
USD
+0.49
- -
Anzu Special Acquisition Corp I
ANZUU
(NASDAQ Capital Market)
Recent
price
7.09
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Anzu Special Acquisition Corp I (ANZUU) is a blank check company, or special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It offers investment opportunities through its public offering of 20,000,000 units at $10.00 each, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant; upon separation, each whole warrant entitles the holder to purchase one Class A ordinary share at $11.50. The company targets businesses in the technology, media, and telecommunications (TMT) sectors, including enterprise software, cybersecurity, IT services, ad tech, cloud services, digital media, entertainment, gaming, and digital consumer platforms. Founded in 2024 and headquartered in New York, New York, Anzu Special Acquisition Corp I operates primarily in the United States and seeks targets across North America, Europe, and Asia. As of late 2025, the company has not announced any major mergers, acquisitions, partnerships, funding rounds beyond its initial public offering, product launches, or strategic shifts within the last 1-2 years, remaining in the search phase for a suitable business combination target.
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
Envoy Medical Appoints David R. Wells as Chief Financial Officer
CORRECTING and REPLACING Anzu Special Acquisition Corp I Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing April 22, 2021